col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


105 Results       Page 1

 [1] 
Elsevier: Computational and Structural Biotechnology Journal
  original article Date Title Authors   All Authors
1 [GO] 2022―May―19 Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern tracking Sara Donzelli, Ludovica Ciuffreda, Martina Pontone, Martina Betti, Alice Massacci, Carla Mottini, et al. (+6)
2 [GO] 2022―May―17 Potential Drug Discovery for COVID-19 Treatment Targeting Cathepsin L Using a Deep Learning-Based Strategy Wei-Li Yang, Qi Li, Jing Sun, Sia Huat Tan, Yan-Hong Tang, Miao-Miao Zhao, et al. (+4)
3 [GO] 2022―May―10 Reconstruction of the Origin of the First Major SARS-CoV-2 Outbreak in Germany Marek Korencak, Sugirthan Sivalingam, Anshupa Sahu, Dietmar Dressen, Axel Schmidt, Fabian Brand, et al. (+5)
4 [GO] 2022―May―02 Computational approach for binding prediction of SARS-CoV-2 with neutralizing antibodies Daria Beshnova, Yan Fang, Mingjian Du, Yehui Sun, Fenghe Du, Jianfeng Ye, et al. (+2)
5 [GO] 2022―Apr―26 SARS-CoV-2 Pan-variant Inhibitory Peptides Deter S1-ACE2 Interaction and Neutralize Delta and Omicron Pseudoviruses Masaud Shah, Sung Ung Moon, Jang Hyun Kim, Trinh Thanh Thao, Hyun Goo Woo
6 [GO] 2022―Apr―21 SARS-CoV-2 mutations acquired during serial passage in human cell lines are consistent with several of those found in recent natural SARS-CoV-2 variants Hoyin Chung, Ji Yeong Noh, Bon-Sang Koo, Jung Joo Hong, Hye Kwon Kim
7 [GO] 2022―Apr―09 Discovery of a new generation of angiotensin receptor blocking drugs: receptor mechanisms and in silico binding to enzymes relevant to covid-19 Harry Ridgway, Graham J. Moore, Thomas Mavromoustakos, Sotiris Tsiodras, Irene Ligielli, Konstantinos Kelaidonis, et al. (+8)
8 [GO] 2022―Mar―18 Both Simulation and Sequencing Data Reveal Coinfections with Multiple SARS-CoV-2 Variants in the COVID-19 Pandemic Yinhu Li, Yiqi Jiang, Zhengtu Li, Yonghan Yu, Jiaxing Chen, Wenlong Jia, et al. (+4)
9 [GO] 2022―Mar―14 Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds Io Antonopoulou, Eleftheria Sapountzaki, Ulrika Rova, Paul Christakopoulos
10 [GO] 2022―Feb―26 Molecular dynamics simulations of the delta and omicron SARS-CoV-2 spike - ACE2 complexes reveal distinct changes between both variants Eileen Socher, Lukas Heger, Friedrich Paulsen, Friederike Zunke, Philipp Arnold
11 [GO] 2022―Feb―24 COVID-19 infection and neurodegeneration: Computational evidence for interactions between the SARS-CoV-2 spike protein and monoamine oxidase enzymes Lucija Hok, Hrvoje Rimac, Janez Mavri, Robert Vianello
12 [GO] 2022―Feb―04 Identification of novel SARS-CoV-2 RNA dependent RNA polymerase (RdRp) inhibitors: From in silico screening to experimentally validated inhibitory activity Tanaporn Uengwetwanit, Nopporn Chutiwitoonchai, Kanin Wichapong, Nitsara Karoonuthaisiri
13 [GO] 2022―Jan―31 Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants Jialing Yin, Chengcheng Li, Chunhong Ye, Zhihui Ruan, Yicong Liang, Yongkui Li, et al. (+2)
14 [GO] 2022―Jan―31 D155Y Substitution of SARS-CoV-2 ORF3a Weakens Binding with Caveolin-1 Suchetana Gupta, Ditipriya Mallick, Kumarjeet Banerjee, Shrimon Mukherjee, Soumyadev Sarkar, Sonny TM Lee, et al. (+2)
15 [GO] 2022―Jan―31 Evaluation of protein descriptors in computer-aided rational protein engineering tasks and its application in property prediction in SARS-CoV-2 spike glycoprotein Hocheol Lim, Hyeon-Nae Jeon, Seungcheol Lim, Yuil Jang, Taehee Kim, Hyein Cho, et al. (+2)
16 [GO] 2022―Jan―29 Montelukast is a dual-purpose inhibitor of SARS-CoV-2 infection and virus-induced IL-6 expression identified by structure-based drug repurposing Max Luedemann, Daniela Stadler, Cho-Chin Cheng, Ulrike Protzer, Percy A. Knolle, Sainitin Donakonda
17 [GO] 2022―Jan―21 Evidence of a SARS-CoV-2 double Spike mutation D614G/S939F potentially affecting immune response of infected subjects Sara Donzelli, Francesca Spinella, Enea Gino di Domenico, Martina Pontone, Ilaria Cavallo, Giulia Orlandi, et al. (+13)
18 [GO] 2022―Jan―11 Probing the Formation, Structure and Free Energy Relationships of M Protein Dimers of SARS-CoV-2 Yipeng Cao, Rui Yang, Wei Wang, Shengpeng Jiang, Chengwen Yang, Ningbo Liu, et al. (+4)
19 [GO] 2021―Dec―11 The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour A. Sofia F. Oliveira, Deborah K. Shoemark, Amaurys Avila Ibarra, Andrew D. Davidson, Imre Berger, Christiane Schaffitzel, Adrian J. Mulholland
20 [GO] 2021―Dec―05 Pandemic Strategies with Computational and Structural Biology against COVID-19: A Retrospective Ching-Hsuan Liu, Cheng-Hua Lu, Liang-Tzung Lin
21 [GO] 2021―Nov―25 Novel dynamic residue network analysis approaches to study allosteric modulation: SARS-CoV-2 Mpro and its evolutionary mutations as a case study Olivier Sheik Amamuddy, Rita Afriyie Boateng, Victor Barozi, Dorothy Wavinya Nyamai, Özlem Tastan Bishop
22 [GO] 2021―Nov―20 Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods Li Gao, Guo-Sheng Li, Jian-Di Li, Juan He, Yu Zhang, Hua-Fu Zhou, et al. (+2)
23 [GO] 2021―Nov―08 Lipidomics and metabolomics signatures of SARS-CoV-2 mediators/receptors in peripheral leukocytes, jejunum and colon Jordi Mayneris-Perxachs, José-Maria Moreno-Navarrete, Marta Ballanti, Giovanni Monteleone, Omero Alessandro Paoluzi, Geltrude Mingrone, et al. (+7)
24 [GO] 2021―Nov―03 A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells Barbara Storti, Paola Quaranta, Cristina Di Primio, Nicola Clementi, Nicasio Mancini, Elena Criscuolo, et al. (+14)
25 [GO] 2021―Oct―09 In silico antibody engineering for SARS-CoV-2 detection Didac Martí, Eduard Martín-Martínez, Juan Torras, Oscar Bertran, Pau Turon, Carlos Alemán
26 [GO] 2021―Oct―05 N-terminal domain mutations of the spike protein are structurally implicated in epitope recognition in emerging SARS-CoV-2 strains Apostolos Klinakis, Zoe Cournia, Theodoros Rampias
27 [GO] 2021―Sep―20 Polyphenols as Alternative Treatments of COVID-19 Yifei Wu, Scott D. Pegan, David Crich, Ellison Desrochers, Edward B. Starling, Madelyn C. Hansen, et al. (+5)
28 [GO] 2021―Sep―03 Computational Insights into the Membrane Fusion Mechanism of SARS-CoV-2 at the Cellular Level Jimin Wang, Federica Maschietto, Matthew J. Guberman-Pfeffer, Krystle Reiss, Brandon Allen, Yong Xiong, et al. (+2)
29 [GO] 2021―Sep―02 Predicted pH-dependent stability of SARS-CoV-2 spike protein trimer from interfacial acidic groups Vanessa R. Lobo, Jim Warwicker
30 [GO] 2021―Sep―01 Superspreading and heterogeneity in transmission of SARS, MERS, and COVID-19: a systematic review Jingxuan Wang, Xiao Chen, Zihao Guo, Shi Zhao, Ziyue Huang, Zian Zhuang, et al. (+5)
31 [GO] 2021―Sep―01 Rapid reconstruction of porcine reproductive and respiratory syndrome virus using synthetic DNA fragments Julien Mélade, Géraldine Piorkowski, Hawa Sophia Bouzidi, Alain Medawar, Claudine Raffy, Xavier de Lamballerie, Antoine Nougairède
32 [GO] 2021―Aug―24 An overview of potential inhibitors targeting non-structural proteins 3 (PLpro and Mac1) and 5 (3CLpro/Mpro) of SARS-CoV-2 Fangfang Yan, Feng Gao
33 [GO] 2021―Aug―19 Docking-Generated Multiple Ligand Poses for Bootstrapping Bioactivity Classifying Machine Learning: Repurposing Covalent Inhibitors for COVID-19-Related TMPRSS2 as Case Study Ma'mon M. Hatmal, Omar Abuyman, Mutasem Taha
34 [GO] 2021―Aug―12 Non-conventional interactions of N3 inhibitor with the main protease of SARS-CoV and SARS-CoV-2 Ponciano García-Gutiérrez, Rafael A. Zubillaga, Ilich A. Ibarra, Ana Martínez, Rubicelia Vargas, Jorge Garza
35 [GO] 2021―Jul―26 Immune evasion of SARS-CoV-2 from interferon antiviral system Yuan-Qin Min, Mengzhuo Huang, Xiulian Sun, Fei Deng, Hualin Wang, Yun-Jia Ning
36 [GO] 2021―Jul―26 Binding Affinity and Mechanisms of SARS-CoV-2 Variants Yanqiang Han, Zhilong Wang, Zhiyun Wei, Igor Schapiro, Jinjin Li
37 [GO] 2021―Jul―10 Exploiting the Molecular Basis of Age and Gender Differences in Outcomes of SARS-CoV-2 Infections. Daniele Mercatelli, Elisabetta Pedace, Pierangelo Veltri, Federico M. Giorgi, Pietro Hiram Guzzi
38 [GO] 2021―Jul―02 Predicted structural mimicry of spike receptor-binding motifs from highly pathogenic human coronaviruses Christopher A. Beaudoin, Arian R Jamasb, Ali F. Alsulami, Liviu Copoiu, Andries J. van Tonder, Sharif Hala, et al. (+5)
39 [GO] 2021―Jun―29 Cardiovascular, Cerebrovascular, and Renal Co-morbidities in COVID-19 Patients: A Systematic-Review and Meta-analysis Abby C. Lee, Wei Tse Li, Lauren Apostol, Jiayan Ma, Pam R. Taub, Eric Y. Chang, et al. (+2)
40 [GO] 2021―Jun―24 Evolution, Correlation, Structural Impact and Dynamics of Emerging SARS-CoV-2 Variants Austin N. Spratt, Saathvik R. Kannan, Lucas T. Woods, Gary A. Weisman, Thomas P. Quinn, Christian L. Lorson, et al. (+3)
41 [GO] 2021―Jun―17 Eleven Routine Clinical Features Predict COVID-19 Severity Uncovered by Machine Learning of Longitudinal Measurements Kai Zhou, Yaoting Sun, Lu Li, Zelin Zang, Jing Wang, Jun Li, et al. (+28)
42 [GO] 2021―Jun―14 Temperature responsive smart polymer for enabling affinity enrichment of current coronavirus (SARS-CoV-2) to improve its diagnostic sensitivity Ahmed Nabil, Erika Yoshihara, Keita Hironaka, Ayman A. Hassan, Gamal Shiha, Mitsuhiro Ebara
43 [GO] 2021―Jun―05 Interaction of 8-Anilinonaphthalene-1-Sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification Peerapon Deetanya, Kowit Hengphasatporn, Patcharin Wilasluck, Yasuteru Shigeta, Thanyada Rungrotmongkol, Kittikhun Wangkanont
44 [GO] 2021―Jun―05 The evolving proteome of SARS-CoV-2 predominantly uses mutation combination strategy for survival L. Ponoop Prasad Patro, Chakkarai Sathyaseelan, Patil Pranita Uttamrao, Thenmalarchelvi Rathinavelan
45 [GO] 2021―May―26 Screening of World Approved Drugs against Highly Dynamical Spike Glycoprotein of SARS-CoV-2 using CaverDock and Machine Learning Gaspar P. Pinto, Ondrej Vavra, Sergio M. Marques, Jiri Filipovic, David Bednar, Jiri Damborsky
46 [GO] 2021―May―24 Prediction of repurposed drugs for Coronaviruses using artificial intelligence and machine learning Akanksha Rajput, Anamika Thakur, Adhip Mukhopadhyay, Sakshi Kamboj, Amber Rastogi, Sakshi Gautam, et al. (+2)
47 [GO] 2021―May―13 Computational optimization of angiotensin-converting enzyme 2 for SARS-CoV-2 Spike molecular recognition. Lorenzo Di Rienzo, Michele Monti, Edoardo Milanetti, Mattia Miotto, Alberto Boffi, Gian Gaetano Tartaglia, Giancarlo Ruocco
48 [GO] 2021―May―07 Artificial Intelligence in clinical care amidst COVID-19 Pandemic: A Systematic Review Eleni S. Adamidi, Konstantinos Mitsis, Konstantina S. Nikita
49 [GO] 2021―May―04 Evidence of a Putative Glycosaminoglycan Binding Site on the Glycosylated SARS-CoV-2 Spike Protein N-terminal domain Zachariah P. Schuurs, Edward Hammond, Stefano Elli, Timothy R. Rudd, Courtney J. Mycroft-West, Marcelo A. Lima, et al. (+11)
50 [GO] 2021―Apr―30 Clinical evaluation of SARS-CoV-2 Lung HRCT and RT-PCR Techniques: Towards risk factor based diagnosis of infectious diseases Fariba Asadi, Razieh Shahnazari, Nikhil Bhalla, Amir Farokh Payam
51 [GO] 2021―Apr―27 Laboratory indicators in COVID-19 and other pneumonias: Analysis for differential diagnosis and comparison of dynamic changes during 400-day follow-up Jing Wang, Yufen Zheng, Yijun Chen, Xingzhong Hu, Minfei Peng, Yicheng Fang, et al. (+2)
52 [GO] 2021―Apr―27 An overview of current COVID-19 vaccine platforms Abdou Nagy, Bader Alhatlani
53 [GO] 2021―Apr―26 Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: lessons from the pandemic and preparing for future health crises Natesh Singh, Bruno O. Villoutreix
54 [GO] 2021―Apr―23 Comparisons of the immunological landscape between COVID-19, influenza, and respiratory syncytial virus patients by clustering analysis Zeinab Abdelrahman, Zuobing Chen, Haoyu Lyu, Xiaosheng Wang
55 [GO] 2021―Apr―16 Targeting protein-protein interaction interfaces in COVID-19 drug discovery Chung-ke Chang, Shan-Meng Lin, Roshan Satange, Shih-Chao Lin, Sin-Cih Sun, Hung-Yi Wu, et al. (+2)
56 [GO] 2021―Apr―08 Dependence of SARS-CoV-2 infection on cholesterol-rich lipid raft and endosomal acidification Xiaowei Li, Wenhua Zhu, Meiyang Fan, Jing Zhang, Yizhao Peng, Fumeng Huang, et al. (+6)
57 [GO] 2021―Apr―07 Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity Sugandh Kumar, Bharati Singh, Pratima Kumari, Preethy V. Kumar, Geetanjali Agnihotri, Shaheerah Khan, et al. (+3)
58 [GO] 2021―Apr―07 Temperature effect on the SARS-CoV-2: A Molecular dynamics study of the spike homotrimeric glycoprotein Didac Martí, Juan Torras, Oscar Bertran, Pau Turon, Carlos Alemán
59 [GO] 2021―Apr―06 Metabolomics reveals sex-specific metabolic shifts and predicts the duration from positive to negative in non-severe COVID-19 patients during recovery process Hong Zheng, Shengwei Jin, Ting Li, Weiyang Ying, Binyu Ying, Dong Chen, et al. (+7)
60 [GO] 2021―Apr―05 AutoVEM: an automated tool to real-time monitor epidemic trends and key mutations in SARS-CoV-2 evolution Binbin Xi, Dawei Jiang, Shuhua Li, Jerome R Lon, Yunmeng Bai, Shudai Lin, et al. (+7)
61 [GO] 2021―Mar―27 Neuropilins: C-end rule peptides and their association with nociception and COVID-19 Amie Jobe, Ranjit Vijayan
62 [GO] 2021―Mar―27 Lung organoid simulations for modelling and predicting the effect of mutations on SARS-CoV-2 Infectivity Sally Esmail, Wayne R Danter
63 [GO] 2021―Mar―23 A model to predict the risk of mortality in severely ill COVID-19 patients Bo Chen, Hongqiu Gu, Yi Liu, Guqin Zhang, Hang Yang, Huifang Hu, et al. (+6)
64 [GO] 2021―Mar―23 SARS-CoV-2 Infection and Smoking: What is the association? A brief review Ishita Gupta, Muhammad Umar Sohail, Khaled E. Elzawawi, Ahmed H. Amarah, Semir Vranic, Maha Al-Asmakh, Ala-Eddin Al Moustafa
65 [GO] 2021―Mar―23 Specific epitopes form extensive hydrogen-bonding networks to ensure efficient antibody binding of SARS-CoV-2: implications for advanced antibody design Daojiong Wang, Yushu Ge, Bin Zhong, Dan Liu
66 [GO] 2021―Mar―19 Structural determinants driving the binding process between PDZ domain of wild type human PALS1 protein and SLiM sequences of SARS-CoV E proteins Ettore Lo Cascio, Angelo Toto, Gabriele Babini, Flavio De Maio, Maurizio Sanguinetti, Alvaro Mordente, et al. (+2)
67 [GO] 2021―Mar―02 The Conundrum of Giglio Island: unraveling the dynamics of an apparent resistance to COVID-19 - A descriptive study Antonio Bognanni, Armando Schiaffino, Fulvia Pimpinelli, Sara Donzelli, Ilaria Celesti, Sabrina Strano, et al. (+13)
68 [GO] 2021―Mar―02 Deep learning for COVID-19 chest CT (computed tomography) image analysis: a lesson from lung cancer Hao Jiang, Shiming Tang, Weihuang Liu, Yang Zhang
69 [GO] 2021―Mar―02 COVID-19 pandemic: Can zinc supplementation provide an additional shield against the infection? Mohammed S. Razzaque
70 [GO] 2021―Feb―27 Antioxidants and pentoxifylline as coadjuvant measures to standard therapy to improve prognosis of patients with pneumonia by COVID-19 Adrián Palacios Chavarria, Rafael Ricardo Valdez Vázquez, José Guillermo Domínguez Cherit, Héctor Herrera Bello, Humberto Castillejos Suastegui, Lidia Moreno-Castañeda, et al. (+9)
71 [GO] 2021―Feb―21 Ultra-large-scale ab initio quantum chemical computation of bio-molecular systems: the case of Spike protein of SARS-CoV-2 virus Wai-Yim Ching, Puja Adhikari, Bahaa Jawad, Rudolf Podgornik
72 [GO] 2021―Feb―09 3044 cases reveal important prognosis signatures of COVID-19 patients Shijie Qin, Weiwei Li, Xuejia Shi, Yanjun Wu, Canbiao Wang, Jiawei Shen, et al. (+18)
73 [GO] 2021―Jan―30 The Paradoxical Problem with COVID-19 Ocular Infection: Moderate Clinical Manifestation and Potential Infection Risk Jiawei Shen, Jian Wu, Yang Yang, Pengcheng Wang, Tao Luo, Yanju Guo, et al. (+9)
74 [GO] 2021―Jan―30 Current concepts in the development of therapeutics against human and animal coronavirus diseases by targeting NP Yeu-Yang Tseng, Guan-Ru Liao, Abigail Lien, Wei-Li Hsu
75 [GO] 2021―Jan―27 Chemokines and chemokine receptors during COVID-19 infection Bariaa A. Khalil, Noha Mousaad Elemam, Azzam A. Maghazachi
76 [GO] 2021―Jan―14 Managing children with brain tumors during the COVID-19 era: don’t stop the care! Michele Antonio Capozza, Silvia Triarico, Giorgio Attinà, Alberto Romano, Stefano Mastrangelo, Palma Maurizi, et al. (+8)
77 [GO] 2021―Jan―14 Unraveling the molecular basis of host cell receptor usage in SARS-CoV-2 and other human pathogenic β-CoVs Camila Pontes, Victoria Ruiz-Serra, Rosalba Lepore, Alfonso Valencia
78 [GO] 2020―Dec―31 Novel coronavirus disease (COVID-19) pandemic: A recent mini review Muhammad Fayyaz ur Rehman, Chaudhary Fariha, Aqsa Anwar, Naveed Shahzad, Munir Ahmad, Salma Mukhtar, Muhammad Farhan Ul Haque
79 [GO] 2020―Dec―31 Computational Design of SARS-CoV-2 Spike Glycoproteins to Increase Immunogenicity by T Cell Epitope Engineering Edison Ong, Xiaoqiang Huang, Robin Pearce, Yang Zhang, Yongqun He
80 [GO] 2020―Dec―29 Computational modelling supports that Dengue virus envelope antibodies can bind to SARS-CoV-2 receptor binding sites: Is pre-exposure to dengue virus protective against COVID-19 severity? Himadri Nath, Abinash Mallick, Subrata Roy, Soumi Sukla, Subhajit Biswas
81 [GO] 2020―Dec―29 Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2 Abhinit Kumar, Saurabh Loharch, Sunil Kumar, Rajesh P Ringe, Raman Parkesh
82 [GO] 2020―Dec―28 Spontaneous binding of potential COVID-19 drugs (Camostat and Nafamostat) to human serine protease TMPRSS2 Haixia Zhu, Wenhao Du, Menghua Song, Qing Liu, Andreas Herrmann, Qiang Huang
83 [GO] 2020―Dec―25 Meta-analysis of Transcriptome Datasets: an Alternative Method to Study IL-6 Regulation in Coronavirus Disease 2019 Hui Liu, Shujin Lin, Xiulan Ao, Xiangwen Gong, Chunyun Liu, Dechang Xu, et al. (+6)
84 [GO] 2020―Dec―18 Host transcriptomic profiling of COVID-19 patients with mild, moderate, and severe clinical outcomes Ruchi Jain, Sathishkumar Ramaswamy, Divinlal Harilal, Mohammed Uddin, Tom Loney, Norbert Nowotny, et al. (+7)
85 [GO] 2020―Dec―17 Temperature Dependence of the SARS-CoV-2 affinity to human ACE2 determines COVID-19 progression and clinical outcome Zhonghua Zhou, Ziyi Yang, Junxian Ou, Hong Zhang, Qiwei Zhang, Ming Dong, Gong Zhang
86 [GO] 2020―Dec―06 Transcriptomic signatures and repurposing drugs for COVID-19 patients: findings of bioinformatics analyses Guobing Li, Xiaolu Zhao, Qi Liu, Shasha Ruan, Yali Dou, Fengbiao Mao
87 [GO] 2020―Dec―06 L1000 Connectivity Map interrogation identifies candidate drugs for repurposing as SARS-CoV-2 antiviral therapies Wezi Sendama
88 [GO] 2020―Dec―04 A recent origin of Orf3a from M protein across the coronavirus lineage arising by sharp divergence Christos A. Ouzounis
89 [GO] 2020―Nov―29 ACE2 partially dictates the host range and tropism of SARS-CoV-2 Shan Gao, Leiliang Zhang
90 [GO] 2020―Nov―20 Utilizing microbiome approaches to assist source tracking, treatment and prevention of COVID-19: Review and Assessment Maozhen Han, Yuguo Zha, Hui Chong, Chaofang Zhong, Kang Ning
91 [GO] 2020―Nov―20 Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2 Desh Deepak Singh, Ihn Han, Eun-Ha Choi, Dharmendra Kumar Yadav
92 [GO] 2020―Nov―20 SARS-CoV2 infectivity is potentially modulated by host redox status Jaswinder Singh, Rajinder S. Dhindsa, Vikram Misra, Baljit Singh
93 [GO] 2020―Nov―12 Mutations in the SARS-CoV-2 Spike RBD are responsible for stronger ACE2 binding and poor anti-SARS-CoV mAbs cross-neutralization Masaud Shah, Bilal Ahmad, Sangdun Choi, Hyun Goo Woo
94 [GO] 2020―Nov―11 In silico and In vitro Studies Reveal Complement System Drives Coagulation Cascade in SARS-CoV-2 Pathogenesis Ritudhwaj Tiwari, Anurag R. Mishra, Flora Mikaeloff, Soham Gupta, Ali Mirazimi, Siddappa N. Byrareddy, et al. (+2)
95 [GO] 2020―Nov―11 Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor Boyu Pan, Senbiao Fang, Ju Zhang, Ya Pan, Han Liu, Yun Wang, et al. (+2)
96 [GO] 2020―Oct―21 Side chain similarity comparisons for integrated drug repositioning and potential toxicity assessments in epidemic response scenarios: the case for COVID-19 Nur Syatila Ab Ghani, Reeki Emrizal, Haslina Makmur, Mohd Firdaus-Raih
97 [GO] 2020―Oct―01 Structural Insight into the Recognition of S-Adenosyl-L-Homocysteine and Sinefungin in SARS-CoV-2 Nsp16/Nsp10 RNA Cap 2’-O-Methyltransferase Panupong Mahalapbutr, Napat Kongtaworn, Thanyada Rungrotmongkol
98 [GO] 2020―Sep―24 Tailoring Time Series Models For Forecasting Coronavirus Spread: Case Studies of 187 Countries Leila Ismail, Huned Materwala, Taieb Znati, Sherzod Turaev, Moien A.B. Khan
99 [GO] 2020―Sep―18 An immersive journey to the molecular structure of SARS-CoV-2: Virtual Reality in COVID-19 Martín Calvelo, Ángel Piñeiro, Rebeca Garcia-Fandino
100 [GO] 2020―Sep―18 Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity Ratul Chowdhury, Veda Sheersh Boorla, Costas D. Maranas
101 [GO] 2020―Aug―26 Potential clinical drugs as covalent inhibitors of the priming proteases of the spike protein of SARS-CoV-2 Qizhang Li, Zhiying Wang, Qiang Zheng, Sen Liu
102 [GO] 2020―Aug―12 Structural Insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein Abbas Khan, Muhammad Tahir Khan, Shoaib Saleem, Muhammad Junaid, Arif Ali, Syed Shujait Ali, et al. (+2)
103 [GO] 2020―Jul―31 Unlocking COVID therapeutic targets: a structure-based rationale against SARS-CoV-2, SARS-CoV and MERS-CoV Spike João Trigueiro-Louro, Vanessa Correia, Inês Figueiredo-Nunes, Marta Gíria, Helena Rebelo-de-Andrade
104 [GO] 2020―Jul―17 Genus-specific pattern of intrinsically disordered central regions in the nucleocapsid protein of coronaviruses Sailen Barik
105 [GO] 2020―Mar―30 Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model Bo Ram Beck, Bonggun Shin, Yoonjung Choi, Sungsoo Park, Keunsoo Kang
 [1] 

105 Results       Page 1



[de][en]

Last change 2022―Feb―03 17:06:14 UTC

© Daten-Quadrat 2022       Done in 0.013 sec